A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes

In this study, we propose a new mathematical model able to quantify C-peptide secretion and β-cell responsivity in response to a glucagon bolus in individuals without and with type 2 diabetes. We show that individuals with type 2 diabetes exhibit reduced β-cell responsivity to glucagon.